Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Cerilliant
Colorcon
AstraZeneca
Mallinckrodt
Argus Health
Fish and Richardson
Queensland Health
UBS
Covington

Generated: December 11, 2017

DrugPatentWatch Database Preview

DECLOMYCIN Drug Profile

« Back to Dashboard

When do Declomycin patents expire, and what generic alternatives are available?

Declomycin is a drug marketed by Lederle and Corepharma and is included in three NDAs.

The generic ingredient in DECLOMYCIN is demeclocycline hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the demeclocycline hydrochloride profile page.
Drug patent expirations by year for DECLOMYCIN

Medical Subject Heading (MeSH) Categories for DECLOMYCIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
LederleDECLOMYCINdemeclocycline hydrochlorideCAPSULE;ORAL050262-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
CorepharmaDECLOMYCINdemeclocycline hydrochlorideTABLET;ORAL050261-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleDECLOMYCINdemeclocycline hydrochlorideSYRUP;ORAL050257-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
CorepharmaDECLOMYCINdemeclocycline hydrochlorideTABLET;ORAL050261-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
CorepharmaDECLOMYCINdemeclocycline hydrochlorideTABLET;ORAL050261-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Cantor Fitzgerald
Accenture
Medtronic
Cipla
Covington
Julphar
Mallinckrodt
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot